The New Angiotherapy

1 Vasculogenesis and Angiogenesis.- 2 Angiogenesis-Regulating Cytokines.- 3 The Angiopoietins.- 4 Regulation of Vascular Morphogenesis by Extracellular Matrix Proteins.- 5 Integrin Receptors and the Regulation of Angiogenesis.- 6 Vasoactive Peptides in Angiogenesis.- 7 Angiogenesis in Wound Healing and Surgery.- 8 Angiogenesis and Vascular Endothelial Growth Factor (VEGF) in Reproduction.- 9 Rheumatoid Arthritis: A Target for Anti-Angiogenic Therapy?.- 10 Diagnostic and Prognostic Significance of Tumor Angiogenesis.- 11 Hyaluronan Oligosaccharides Promote Wound Repair: Its Size-Dependent Regulation of Angiogenesis.- 12 Role of Thymic Peptides in Wound Healing.- 13 Angiogenesis and Growth Factors in Ulcer Healing.- 14 Angiogenesis in Skeletal and Cardiac Muscle: Role of Mechanical Factors.- 15 Therapeutic Angiogenesis for the Treatment of Cardiovascular Disease.- 16 Therapeutic Angiogenesis for the Heart.- 17 Contact-Guided Angiogenesis and Tissue Engineering.- 18 Inhibitors of Matrix Metalloproteinases.- 19 Control of Angiogenesis by Microbial Products.- 20 Interaction of Angiogenic Growth Factors with Endothelial Cell Heparan Sulfate Proteoglycans: Implications for the Development of Angiostatic Compounds.- 21 2-Methoxyestradiol: A Novel Endogenous Chemotherapeutic and Anti-Angiogenic Agent.- 22 Receptor Tyrosine Kinases in Angiogenesis.- 23 Targeting Gene Therapy to the Tumor Vasculature.- 24 Antibody Targeting of Tumor Vasculature.- 25 Endothelial Monocyte-Activating Polypeptide II: A Novel Injury Signal?.- 26 CD105 Antibody for Targeting of Tumor Vascular Endothelial Cells.- 27 Design of Pharmacological and Diagnostic Strategies for Angiogenesis-Dependent Diseases.- 28 Design of Clinical Trials for Anti-Angiogenics.- 29 Angiogeneis Therapies: Concepts, Clinical Trials, and Considerations for New Drug Development.- 30 Angiostatin and Endostatin: Recent Advances in Their Biology, Pharmacokinetics, and Potential Clinical Applications.